Taconic Capital Advisors’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Taconic Capital Advisors’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500,000	Closed	-$5.14M	–	403
2022 Q4	$5.14M	Hold	500,000	–	–	0.15%	148
2022 Q3	$5.03M	Hold	500,000	–	–	0.12%	180
2022 Q2	$5.03M	Hold	500,000	–	–	0.13%	177
2022 Q1	$4.94M	Buy	+500,000	New	+$4.93M	0.13%	172

Other funds holding BIOS

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Taconic Capital Advisors's BIOS Position: Q1 2023 in Review

Taconic Capital Advisors sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q1 2023, closing a stake of 500,000 shares — an estimated $5.14M sold.

Taconic Capital Advisors first reported a position in BIOS in Q1 2022 and held it in 4 quarters. The position peaked at $5.14M in Q4 2022. 61 funds tracked by Wall St. Rank hold BIOS as of Q1 2023.

Taconic Capital Advisors reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Taconic Capital Advisors sold 500,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $5.14M.
Taconic Capital Advisors first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 4 quarters.
Taconic Capital Advisors's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $5.14M in Q4 2022.
61 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Taconic Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.